These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4305290)

  • 21. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 23. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-resistant pulmonary tuberculosis.
    Kossmann CE
    J Tenn Med Assoc; 1978 Dec; 71(12):905-7, 909. PubMed ID: 756916
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P; Schilling W
    Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis].
    Porokhnia VV; Khomenko VV; Petrovich DI; Iusukhno EE; Skvira VP
    Probl Tuberk; 1989; (3):64-7. PubMed ID: 2726715
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of vitamins on general condition of the T- and B-immunity systems during antibacterial treatment of pulmonary tuberculosis].
    Volosevich GV
    Probl Tuberk; 1978 Oct; (10):36-9. PubMed ID: 309606
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reasons for failures in chemotherapy of tuberculosis].
    Dissmann E
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of INH- and streptomycin-resistant patients].
    Böszörményi M; Schweiger O
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):329-31. PubMed ID: 5897861
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the current early therapy methods of exsudative pulmonary tuberculosis in adults].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1969 Jun; 119(25):492-3. PubMed ID: 4308395
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and bacteriological problems of ethionamide therapy].
    Lányi M
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):332-4. PubMed ID: 5897862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M
    Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of tuberculosis.
    Lester W
    Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
    [No Abstract]   [Full Text] [Related]  

  • 39. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
    el-Fassi el-Fahri M; Burzoni FJ; Durante C; Ceicu A
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():158-65. PubMed ID: 4611550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.